Aurobindo Pharma Limited (AUROPHARMA) — Net Asset Quality Index
Aurobindo Pharma Limited (AUROPHARMA) has a Net Asset Quality Index of 66.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs525.46 Billion minus total liabilities of Rs175.12 Billion yields net assets of Rs350.34 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Aurobindo Pharma Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Aurobindo Pharma Limited Net Asset Quality Index Over Time (2004–2025)
This chart shows how Aurobindo Pharma Limited's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of September 2025, the index stands at 66.7%, representing net assets of Rs350.34 Billion against total assets of Rs525.46 Billion INR. See Aurobindo Pharma Limited (AUROPHARMA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Aurobindo Pharma Limited (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for Aurobindo Pharma Limited from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see AUROPHARMA stock market capitalisation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.6% | Rs326.47 Billion | Rs497.85 Billion | Rs171.38 Billion | ▼ -0.7 pp |
| 2024 | 66.2% | Rs298.51 Billion | Rs450.72 Billion | Rs152.21 Billion | ▼ -1.1 pp |
| 2023 | 67.3% | Rs268.52 Billion | Rs398.90 Billion | Rs130.38 Billion | ▼ -5.1 pp |
| 2022 | 72.4% | Rs245.74 Billion | Rs339.22 Billion | Rs93.48 Billion | ▲ +7.7 pp |
| 2021 | 64.8% | Rs219.29 Billion | Rs338.54 Billion | Rs119.25 Billion | ▲ +6.6 pp |
| 2020 | 58.2% | Rs168.25 Billion | Rs289.28 Billion | Rs121.03 Billion | ▲ +5.6 pp |
| 2019 | 52.5% | Rs138.92 Billion | Rs264.54 Billion | Rs125.62 Billion | ▼ -2.8 pp |
| 2018 | 55.4% | Rs116.82 Billion | Rs211.01 Billion | Rs94.19 Billion | ▼ -2.3 pp |
| 2017 | 57.7% | Rs93.74 Billion | Rs162.49 Billion | Rs68.75 Billion | ▲ +14.9 pp |
| 2016 | 42.8% | Rs68.18 Billion | Rs159.20 Billion | Rs91.02 Billion | ▲ +2.7 pp |
| 2015 | 40.1% | Rs51.82 Billion | Rs129.14 Billion | Rs77.33 Billion | ▲ +0.3 pp |
| 2014 | 39.8% | Rs37.76 Billion | Rs94.90 Billion | Rs57.14 Billion | ▲ +3.8 pp |
| 2013 | 36.0% | Rs26.22 Billion | Rs72.78 Billion | Rs46.56 Billion | ▼ -1.6 pp |
| 2012 | 37.7% | Rs23.50 Billion | Rs62.38 Billion | Rs38.88 Billion | ▼ -4.0 pp |
| 2011 | 41.7% | Rs24.49 Billion | Rs58.72 Billion | Rs34.23 Billion | ▲ +3.4 pp |
| 2010 | 38.3% | Rs18.33 Billion | Rs47.91 Billion | Rs29.58 Billion | ▲ +8.8 pp |
| 2009 | 29.4% | Rs12.44 Billion | Rs42.26 Billion | Rs29.82 Billion | ▼ -1.6 pp |
| 2008 | 31.0% | Rs11.27 Billion | Rs36.34 Billion | Rs25.07 Billion | ▲ +5.6 pp |
| 2007 | 25.4% | Rs8.90 Billion | Rs35.06 Billion | Rs26.17 Billion | ▼ -5.0 pp |
| 2006 | 30.4% | Rs8.17 Billion | Rs26.89 Billion | Rs18.72 Billion | ▼ -3.2 pp |
| 2005 | 33.5% | Rs7.14 Billion | Rs21.30 Billion | Rs14.15 Billion | ▼ -5.3 pp |
| 2004 | 38.9% | Rs7.25 Billion | Rs18.66 Billion | Rs11.41 Billion | — |